The Ultrasound Guided Versus Land-mark Location Method for Performing Spinal Anesthesia in Obese Parturients

January 24, 2023 updated by: Karaman Training and Research Hospital

Comparison of Ultrasound and Anatomical Land-mark Method in Spinal Anesthesia for Elective Cesarean Section in Obese Parturients With BMI ≥ 40 kg/m2. A Randomized Controlled Trial

This study will be investigated whether an ultrasound-assisted technique is better than a classical land-mark technique to facilitate spinal anesthesia in the lateral position in morbidly obese pregnant women with BMI ≥ 40 who will undergo elective cesarean section.

The primary objective in this study is the rate of successful dural puncture at the first attempt. It was assumed that ultrasound could facilitate neuraxial blockade in grade 3 morbidly obese pregnant women according to the Who classification, whose topographic anatomy is difficult.

Study Overview

Status

Completed

Conditions

Detailed Description

Spinal anesthesia is the most commonly used anesthesia method for elective cesarean deliveries. Anesthesiologists may have difficulties in determining the poorly palpable surface landmarks in morbidly obese pregnant women.

Manual palpation technique, which is preferred in neuraxial anesthesia, may be difficult in obese pregnant women due to the difficulty in identifying bone landmarks. Neuraxial ultrasound examination before spinal anesthesia may help spinal anesthesia performance and decrease number of attempts in obese parturients.

This study will be conducted as a single-center, prospective, randomized, double-blinded trial in a university hospital. Patients scheduled for elective cesarean will be screened for enrollment in the study. Patient, the anesthetist administering spinal anesthesia and evaluating the data were blind to the distribution of patient groups.Ultrasonographic examinations were performed by a single investigator trained in this technique who performed more than 150 ultrasound-guided neuraxial blocks.

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Karaman, Turkey, 70200
        • Karaman Training and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Parturient who will receive selective cesarean delivery under spinal anesthesia
  • ASA 2-3 scheduled for elective sections
  • BMI≥40 kg/m2
  • normal singleton pregnancy
  • ≥37 weeks of gestation

Exclusion Criteria:

  • Multiple gestations
  • Emergency C-section
  • exist contraindications of spinal anesthesia
  • Local anesthetics allergy
  • BMI<40 kg/m2
  • history of lumbar spinal diseases and lumbar surgery
  • Parturient refusal

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Ultrasound group
Ultrasound assited technique will be used for spinal anesthesia performance.

In the operating room, all of the patients will receive standard monitoring. Scans will be made in logiditunal parasagittal and transverse midline views with ultrasound. Needle entry sites in the L2-L3 and L3-L4 intervals will be determined as the intersection of the longiditunal and transverse lines.

When the spinal puncture operator is outside the room, Needle entry sites were marked for both groups.After skin marking, the pregnant woman will be asked to remain still and a subarachnoid puncture will be performed immediately. Spinal anesthesia will be administered with injection of intrathecal bupivacaine.

Experimental: Landmark group
Land-mark assisted technique will be used for spinal anesthesia performance.
In the Landmark group, the injection site will be determined using the traditional method of palpating the posterior superior iliac spine.When the spinal puncture operator is outside the room, Needle entry sites were marked for both groups.After skin marking, the pregnant woman will be asked to remain still and a subarachnoid puncture will be performed immediately. Spinal anesthesia will be administered with injection of intrathecal bupivacaine.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The success rate of first puncture
Time Frame: 30 minute
Success on a single-puncture attempt will be defined as reaching the subarachnoid space on the first insertion of the needle.
30 minute

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of skin punctures
Time Frame: 30 minute
Skin puncture is defined as any separate skin puncture attempt.
30 minute
Number of needle pass
Time Frame: 30 minute
Needle pass is defined as skin puncture plus number of redirection attempts
30 minute
The procedure duration time
Time Frame: 30 minute
The duration from initiation of location marking by palpation or ultrasound to obtaining free cerebrospinal fluid flow
30 minute
Time interval to determine needle insertion site
Time Frame: 30 minute
Time interval between the operator touches the parturient and the completion of the needle insertion point marking
30 minute
Time taken for spinal injection
Time Frame: 30 minute
The time interval between the needle insertion to visualization of cerebrospinal spinal fluid in the spinal needle.
30 minute
Number of puncture levels
Time Frame: 30 minute
Move to a second lumbar space after 3 needle insertion attempts
30 minute
Patient satisfaction The procedure duration
Time Frame: 30 minute
Patients rated their satisfaction as very satisfied, satisfied, or dissatisfied immediately after the procedure.
30 minute
incidence of complications during puncture
Time Frame: 30 minute
Incidence of radicular pain, paresthesia, and blood during spinal needle injection
30 minute
incidence of postoperative headache
Time Frame: 72 hour
12-72 hours following spinal anesthesia due to CSF leakage
72 hour
Incidence of hypotension
Time Frame: 2 hour
A systolic arterial pressure decrease of more than 25% from baseline or less than 90 mmHg
2 hour
Failure rate of spinal anesthesia
Time Frame: 120 minute
Number of parturients who need additional analgesic drug or conversion to general anesthesia
120 minute
dermatome level of sensory block [ Time Frame: 10 minutes after spinal anesthetic injection ]
Time Frame: 20 minute
thoracic dermatome level of sensory block assessed by pinprick test
20 minute

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Betül Başaran, MD,DESA, Karaman Training and Research Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 23, 2022

Primary Completion (Actual)

January 23, 2023

Study Completion (Actual)

January 24, 2023

Study Registration Dates

First Submitted

April 18, 2022

First Submitted That Met QC Criteria

April 18, 2022

First Posted (Actual)

April 25, 2022

Study Record Updates

Last Update Posted (Estimate)

January 25, 2023

Last Update Submitted That Met QC Criteria

January 24, 2023

Last Verified

April 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 02-2022/02

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Morbid Obesity

Clinical Trials on Ultrasound group

Subscribe